We identified a novel exonic mutation which causes exon skipping in the mitochondrial acetoacetyl-CoA thiolase (T2) gene from a girl with T2 deficiency (GK07). GK07 is a compound heterozygote; the maternal allele has a novel G to T transversion at position 1136 causing Gly379 to Val substitution (G379V) of the T2 precursor. In case of in vivo expression analysis, cells transfected with this mutant cDNA showed no evidence of restored T2 activity. The paternal allele was associated with exon 8 skipping at the cDNA level. At the gene level, a C to T transition causing Gln272 to termination codon (Q272STOP) was identified within exon 8, 13 bp from the 5' splice site of intron 8 in the paternal allele. The mRNA with Q272STOP could not be detected in GK07 fibroblasts, presumably because pre-mRNA with Q272STOP was unstable because of the premature termination. In vivo splicing experiments revealed that the exonic mutation caused partial skipping of exon 8. This substitution was thought to alter the secondary structure of T2 pre-mRNA around exon 8 and thus impede normal splicing. The role of exon sequences in the splicing mechanism is indicated by the exon skipping which occurred with an exonic mutation.
Introduction
Mitochondrial acetoacetyl-CoA thiolase (T2,' EC 2.3.1.9) deficiency (,3-ketothiolase deficiency, 2-methylacetoacetic aciduria, McKusick 203750) is an inborn error of isoleucine and ketone body catabolism characterized by intermittent ketoacidotic episodes and urinary excretion of 2-methylacetoacetate, 2-methyl-3-hydroxybutyrate, and tiglylglycine (1) (2) (3) (4) . Fibroblasts from one patient with this disorder lacked the T2 protein because of a defect in its biosynthesis (5) . However, there is molecular heterogeneity in defects of T2 protein (6) . Human T2 cDNA is about 1.5 kb and encodes the 424-amino acid T2 precursor (7) . The 27-kb human T2 gene, with 12 exons and 11 introns (8) , is located on chromosome 1 lq22.3-q23.1 (9) . In five different families, we identified seven gene mutations responsible for this disease (10) (11) (12) (13) . Among them, four mutations at 5' or 3' splice sites caused skipping ( I I,12) or aberrant splicing (13) of the corresponding exon. Conservation of nucleotide sequences of 5' and 3' splice sites and the branch site are critical for accurate splicing. However, these events alone cannot account for accuracy of the splicing. Recent studies suggest that exonic sequences and a secondary structure of the RNA precursor have essential information for accurate splice site selection (14) (15) (16) (17) (18) .
We describe herein the molecular basis ofT2 deficiency in a 3-yr-old girl (GK07). In one of her mutant alleles, a novel mutation within exon 8 resulted in partial skipping of exon 8. We clarified this phenomenon in in vivo splicing experiments.
Methods
Case. GKO7 is a Caucasian girl born in 1986 to nonconsanguineous parents. The diagnosis ofT2 deficiency was made when she was 3 yr old and after multiple ketoacidotic attacks. The patient's growth and development were normal, and there was no mental retardation. Protein analyses. Fibroblasts from GKO7 and her parents were cultured in Eagle's MEM containing 10% FCS. Enzyme assay, immunoblot analysis, and pulse-chase experiments were done, as described elsewhere (5, 1 1 ).
Reverse transcription and PCR (RT-PCR) andgenomic DNA analyses. Oligonucleotide primers for RT-PCR and genomic DNA amplification around exon 8 were performed as described ( 11 ). RT-PCR and DNA sequence analysis ofproducts subcloned into plasmid were done, as described elsewhere ( 11) . In vivo expression ofT2 cDNAs. Transient expression ofT2 cDNAs was performed as described elsewhere ( 19) . Briefly, full length normal and mutant cDNAs were subcloned separately into an in vivo expression vector, pCAGGS (20) . 2 ug of plasmid was transfected with TransfectAce (GIBCO BRL, Gaithersburg, MD) into 5 X 105 SV40transformed fibroblasts from GKO3, a T2-deficient patient in whom T2 mRNA was strikingly decreased (7) . Cells were harvested 72 h after transfection and were assayed for T2 activity.
Secondary structure predictions. Normal and mutant sequences of exon 8 with dinucleotides of the 5' and 3' splice sites were analyzed by Zuker and Stiegler's method (21 ) using DNASIS-MAC software (Hitachi Software Engineering Co., Yokohama, Japan).
In vivo splicing experiments. Details ofthe methods are given in the legend to Fig. 7 . Primers used are as follows, and underlined nucleotides are mismatches or linker sequences: A primer on exon 7 sequence (5'-AGCTGTGCTGAGAAT-TCAGC-3'); Figure 1. Pulse-chase experiments of fibroblasts. Fibroblasts from patient GK07 and a control individual were pulse labeled with Tran "S-label (ICN Biomedicals, Inc., Costa Mesa, CA) for 1 h and were chased for 6, 24, and 72 h. Cell extracts were immunoprecipitated with anti-rat T2 IgG and were applied to SDS-PAGE. In control lanes, one-third the amount of immunoprecipitates was applied. Arrows indicate T2 subunits. C primer on exon 7 sequence (5'-TACCAGAAGTAAAGCAGC-AT-3'); and D primer on rabbit fl-globin sequence (3'-GTCCGTGTGTG-ATGGTG-5').
Rabbit f3-globin primer sequence was obtained as described (22) .
Quantitative estimation ofPCR products. Estimation ofthe ratio of mRNA species with/without exon 8 sequence was made as follows. Two plasmids containing cDNA fragments with and without exon 8 sequence were diluted to fg order. The plasmids were mixed with resulting ratios of 10:1, 10:2, 10:3, 10:4, and 10:5 with/without exon 8. PCR amplification was done using these mixed plasmids, the first strand cDNA generated from GKO7 fibroblasts, and "P-end-labeled primer in 15, 20, and 25 cycles. Products were electrophoresed on a 5% acrylamide gel followed by fluorography and densitometric analysis. The intensities ofbands with/without exon 8 sequence from the cDNA pool were compared with those from the mixed plasmids of differencing ratios. The ratio of exon 8-plus/exon 8-minus mRNA species was determined to be that of the comparable mixed plasmid samples.
Results
Protein analyses. T2 enzyme activities of skin fibroblast extracts from patient GKO7 and her parents are shown in Table I . Extract from GKO7 was deficient in T2, as deduced from the failure of K+ to increase acetoacetyl-CoA thiolase activity. T2 activities in the parents were consistent with heterozygosity for T2 deficiency with +K+/-K+ values intermediate between The acetoacetyl-CoA thiolase activity determined in the absence (-K+) or in the presence (+KF) and the ratio of these two activities (+K+/-K+) is listed. The activity with 3-ketooctanoyl-CoA was determined in the presence of K+. Enzyme activities were determined as milliunits per milligram of protein.
the patient and controls. Fibroblast extracts from patient GKO7 and her parents showed levels of acetoacetyl-CoA (-K+) and 3-ketooctanoyl-CoA thiolase activities comparable with findings in the controls. Immunoblot analysis offibroblast extracts revealed that T2 protein was absent in GKO7 (data not shown). Fibroblast T2 protein was decreased in both parents, as compared with findings in control extracts (data not shown). Pulse-chase experiments of T2 protein are shown in Fig. 1 . T2 protein of GKO7 present at 1 h was not detectable with a 6-h chase, while that of the control was evident with a 72-h chase. Thus, T2 protein generated by GKO7 was apparently unstable.
Identification ofmutations in T2 cDNAfrom patient GKO7. Amplified cDNA fragments were analyzed by electrophoresis on a 2% agarose gel ( Fig. 2 A) . A single band of the expected size was obtained in fragments A, B, and C from the patient's mother (M). Amplification of cDNA from the patient GKO7 (P) and her father (F) revealed an additional fragment smaller than that of the expected size by 100 bp in fragments B and C (arrows). The amount ofshorter fragments was about one-fifth that of the normal fragment, as estimated by densitometric analysis of these fragments amplified with 32P-labeled primers. Amplified T2 cDNA fragments of patient GK07's family. A shows electrophoresis on 2.0% agarose gel. The coding region of T2 cDNA was amplified in three separate fragments, A, B, and C, as shown in the lower panel. ATG and TAG indicate positions ofthe initiator methionine codon and the termination codon of T2 cDNA, respectively. M, P. and F indicate the mother, patient (GK07), and father, respectively. Arrows indicate the fragment which is 100 bp smaller than that of the expected size. B and C show Southern blot analysis of amplified C fragments with exon 8 and exon 9 probes, respectively. Exon 8 and exon 9 probes were obtained by genomic amplifications with In 7B I 5'-ATTCTAGATGAGTGT-TTACTTGG-3'] and In 8A [3'-GTCATATAG-TCCGAGTACA-5'], and In 8B [5'-TGCAGT-TAGCTGTGTACATG-3'] and In 9A [3'-ATCGACTCGTACCACCGTACTAGTA-5'], respectively, adding [a-32P]dCTP as substrate. D shows a Southern blot of normal sized C fragments from GKO7 before (-) and after (+) XbaI digestion. If the C fragment with the Q272STOP mutation was present in normal sized C fragment pool from GKO7, 545-and 242-bp fragments should be generated. Two mutations were identified in fragments from GKO7's cDNA fragments. The first was a point mutation, G to T at position 1136, encoding an amino acid change from Gly379 to Val of the T2 precursor (G379V) in the normal sized C fragment ( Fig. 3 A, largerfr. ). This G379V mutation was detected A Smaller fr. in two of five clones of the maternal C fragments, hence this mutation located on exon 11 was inherited from the mother (data not shown). The second was a deletion of positions 731-826 in the smaller B and C fragments. This deletion corresponds precisely to exon 8, indicating that skipping ofthis exon had occurred ( Fig. 3 B) . Because the smaller fragment with exon 8 deleted was present in amplified DNA from the father, but not from the mother of patient GKO7, we considered this deletion to be derived from the paternal allele. Findings in Southern blot analysis of amplified C fragments with exon 8 (Fig. 2 B) and exon 9 ( Fig. 2 C) probes are in accord with the above results. No other mutation was identified in T2 cDNA from GKO7. Characterization of mutant T2 cDNAs. We reported that mutant T2 derived from the mRNA with exon 8 sequence deleted has no thiolase activity, as determined in in vivo transient expression assays (19) . We constructed a full length cDNA with the G379V mutation and subcloned it into the transient expression vector, pCAGGS. The result of enzyme assay after in vivo expression is summarized in Table II . Activation of acetoacetyl-CoA thiolase activity by K+ was nil in cells transfected with either pCAGGST2 (exon 8 deleted) or pCAGGST2 (G379V), whereas activation did occur in cells transfected with pCAGGST2 (normal). We concluded that these mutations are responsible for the T2 deficiency.
The G379V mutation is located in the carboxy-terminal region which is highly conserved among seven reported thiolases (23-29) (Fig. 4) . In (27) ; RT2, rat T2 (28); HT2, human T2 (11); RT1, rat mitochondrial 3-ketoacyl-CoA thiolase (29) ; RPT, rat peroxisomal 3-ketoacyl-CoA thiolase (30) ; and HPT, human peroxisomal 3-ketoacyl-CoA thiolase (31) . These sequences were aligned to achieve maximum homologies. Amino acid residues are numbered beginning at the amino-terminal residues of mature enzymes in the case of T2 and PT. Hence G379V and A380T muta- Figure 5 . Identification of Q272STOP mutation in the exon 8 sequence. Genomic sequences around exon 8 were amplified with primers In 7B and In 8A. A shows the partial nucleotide sequence around the 5' splice site of intron 8. A C to T mutation (Q272STOP) was identified (arrowhead). This mutation creates an XbaI site. Arrows show palindromic sequences enhanced by the mutation. B demonstrates familial analysis with XbaI digestion. Fragments from the father (lane F) and GKO7 were partially digested to 230and 100-bp fragments, hence they are probably heterozygotes of Q272STOP mutation.
ble mutant T2 protein of the normal size was detected by pulse-chase experiments (Fig. 1 ). The mutant protein was likely derived from the T2 mRNA with G379V mutation because the other mutant allele would produce a 33-amino acidtruncated species by skipping of exon 8. We noted in pulsechase experiments, after in vivo transient expression, that the A380T mutation detected in GKO6, adjacent to the G379V mutation, made T2 protein unstable ( 10) . This highly conserved region may be important for stability of thiolase proteins. The precise role of this region remains to be determined.
Identification ofa point mutation in exon 8 associated with exon 8 skipping. The region around exon 8 ofGK07's genomic DNA was amplified and sequenced. We found no evidence ofa substitution in either the 3' splice site of intron 7 or the 5' splice site of intron 8. However, there was a C to T mutation within exon 8 at position -13 from the 5' splice site of intron 8. This change altered the codon in amino acid 272 from glutamine to a termination codon (Q272STOP) and a new XbaI site was created on this mutant allele ( Fig. 5 A) . XbaI restriction assay of the amplified genomic fragments (Fig. 5 B) showed that the Q272STOP mutation was heterozygous in patient GKO7 and Figure 6 . Prediction of pre-mRNA secondary structures around exon 8. Secondary structures of normal and mutant sequences of exon 8 were predicted by Zuker and Stiegler's method (21 ( 14) . This vector transcribes well with an avian fl-actin promoter (AG promoter). The p7-9 plasmid (upper right) includes T2 genomic sequence from a BamHI site of intron 6 to the middle of in-in her father. Normal sized cDNA fragment C from patient GKO7 digested with XbaI followed by Southern blotting (Fig. 2  D) did not reveal an XbaI-digested fragment. Therefore, mRNA with the Q272STOP mutation was not detected in fibroblasts from GKO7. The expression of the Q272STOP mutant allele apparently causes skipping of exon 8.
Prediction of secondary structure. The Q272STOP mutation also lengthens two palindromic sequences, as indicated by the arrows in Fig. 5 A. The predicted pre-mRNA secondary structure of the entire exon 8 sequence was then analyzed (Fig.  6 ). Residue C at site -13 from the 5' splice site in the normal sequence ( Fig. 6 A, encircled) seems to be important for the stem loop structure of the exon 8 sequence, because the C to T x substitution in the mutant sequence resulted in a break in the -x predicted structure, the result being a local stem loop formation just upstream from the 5' splice site (Fig. 6 B) . The predicted local stem loop may prevent the 5' splicing site from forming a spliceosome.
In vivo splicing experiments. To verify that the Q272STOP mutation is the cause of exon 8 skipping in GKO7, in vivo splicing experiments were carried out. Fig. 7 A shows the strategy for construction of vectors to analyze splicing. We prepared three plasmids: pCAGGS7-9 control had the normal sequence; pCAGGS7-9Q272STOP had the mutant sequence with Q272STOP; and pCAGGS7-9gt-.tt had the mutant sequence at the 5' splice site of intron 8, which we previously identified in GKO5 (11) . These constructs ensured that differences among the three vectors were only the mutations we wanted to examine. The three pCAGGS7-9 vectors were expected to express chimeric mRNAs with the 5' half derived from the human T2 sequence and the 3' terminal halfderived from the rabbit f3-globin sequence (Fig. 7 B, lower panel) .
The three pCAGGS7-9 vectors were transfected into both COS-7 cells and human fibroblasts. No significant difference between cell lines was noted in the pattern of amplified fragments. Fig. 7 B shows the results of transfection into human fibroblasts. In cells transfected with the pCAGGS7-9 control, a chimeric cDNA with the exon 8 sequence was amplified (contron 10, which we previously cloned from a normal individual (8) . X indicates XbaI sites. After deletion of XbaI fragments, an exon 7exon 9 region was amplified with A and B primers and with VENT DNA polymerase (New England BioLabs Inc., Beverly, MA), then it was subcloned to the EcoRI site of the pCAGGS vector. Three XbaI fragments around exon 8, including 140 bp of 3' region of the intron 7 and 90 bp of 5' region of the intron 8, were prepared and subcloned into the vector: one had a normal sequence (pCAGGS7-9control), another had the Q272STOP mutation (pCAGGS7-9Q272STOP), and the other had the gt it) tt mutation at the 5' splice site of intron 8, which was derived from GK05's fragment, as described elsewhere (I I) (pCAGGS7-9gt--*tt). These XbaI fragments were sequenced, and no other mutations were detected. (B) Detection of chimeric cDNAs derived from transfected pCAGGS7-9 constructs. 2 ,g ofthe three different pCAGGS7-9 constructs were transfected to 5 X 105 cells of human fibroblasts with TransfectAce (GIBCO BRL) as recommended by the manufacturer. At 48 h after transfection, RNA was extracted from cells using the AGPC method (36) . First strand cDNA was transcribed with D primer from the rabbit ,B-globin sequence and then was amplified with C primer on T2 exon 7 sequence and the D primer. Amplified fragments were electrophoresed on a 10% polyacrylamide gel. Arrows indicate the predicted positions of the normally spliced fragments (Normal) and the fragments lacking the exon 8 sequence (Del. 8).
trol) while the cells transfected with pCAGGS7-9gt-'tt had only a chimeric cDNA lacking exon 8 (lane gt-tt). In the pCAGGS7-9Q272STOP-transfected cells (lane Q272STOP), the mRNA fragment lacking the exon 8 sequence was generated together with that retaining exon 8. The amount of the former was estimated to be one-fourth that of the latter by densitometric analysis of products amplified with 32P-end-labeled primers. Thus, it was clear that the exonic mutation can cause exon 8 skipping.
The discrepancy in the amount of mRNA with exon 8 sequence and the Q272STOP mutation between GKO7 fibroblasts and the transfected cells is attributed to the minigene construct pCAGGS7-9. In fibroblasts from patient GKO7, mRNA with the Q272STOP was prematurely terminated, although mRNA with exon 8 skipping did retain the original reading frame. Premature termination itself causes a marked reduction in the amount of mRNA, except when the termination codon is located in the penultimate or the last exons (30, 31) . Since exon 8 is not the penultimate or the last exon, pre-mRNA with Q272STOP mutation was probably unstable, was degraded rapidly, and was undetectable. On the other hand, the minigene had no efficient initiation ATG codon and lacked an open reading frame. Hence, both minigene mRNAs with/ without exon 8 sequence were in the same state regarding premature termination. In the case ofin vivo splicing experiments such nonfunctional mRNA are detectable because the mRNAs are overexpressed.
Discussion
In this paper, we describe the characterization of two novel mutations in patient GKO7 with T2 deficiency. She was found to be a compound heterozygote who inherited the G379V mutant allele from her mother and the Q272STOP allele from her father. The most striking finding in this work is that the exonic single base substitution (Q272STOP) 13 bases upstream from the 5' splice site of intron 8 resulted in the skipping of exon 8.
In cases of aberrant splicing, the mutations have been identified predominantly in the consensus sequences of the 5' donor (G/gtcag) and 3' acceptor splice sites. We have also reported such cases of typical mutations in T2 deficiency (11) (12) (13) . We first wondered if the Q272STOP mutation alone would be responsible for the skipping of exon 8. However, we observed allelic association between the exonic mutation and exon 8 skipping and could detect no other possible cause ofthe exon skipping. A role for exon sequences and structure in splice site selection has been suggested by several investigators (14-18). Robberson et al. (18) proposed the model of the exon as the unit of assembly in splicing: multiple splicing factors initially recognize sequences at the 3' end of an intron, then the spliceosome assembly machinery searches precursor RNA sequences hunting for the 5' splice site lying a short distance (< 300 bases) downstream of 3' intron sequences through the exon. They term this step "exon definition." This model adequately explains most aberrant splicings (18) . As shown in Fig.  6 , the predicted mRNA secondary structure was altered by the Q272STOP mutation and resulted in a local stem loop structure just upstream of 5' splice site of intron 8. The altered secondary structure may prevent the 5' splice site from assembling splicing factors. We observed previously that a GT to TT transversion at the 5' donor splice site of intron 8 caused the skipping of exon 8 in case of GKO5 (11). This observation indicates that there was probably no usable 5' cryptic site located in the vicinity ofthe authentic site. Hence, exon skipping can occur if the 5' splice site is affected by the Q272STOP mutation. Thus, the single base exonic substitution was considered the cause of skipping of exon 8.
We characterized the effect of the Q272STOP mutation on exon 8 splicing by comparing it with the 5' splice site mutation in in vivo splicing experiments. The control sequence resulted in no skipping of exon 8. In the case of the 5' splice site mutation, a complete skipping of exon 8 was evident as expected. On the other hand, the Q272STOP mutation caused a partial skipping, with about one-fourth of the mRNA carrying the deleted exon 8 sequence. The results suggest that exon definition was partially blocked by the Q272STOP mutation. We propose that alteration of the pre-mRNA secondary structure in the exon 8 sequence by the Q272STOP mutation reduced access of splicing machinery to the 5' splice site ofintron 8 and caused exon 8 skipping in some transcripts.
To our knowledge, there are only two precedents of exonic mutation which may affect 5' splice site selection. Ricketts et al. (32) identified two mutations in exon 9 ofthe bovine thyroglobulin gene that were associated with skipping ofexon 9. One was a nonsense mutation and the other was a C to G mutation located at positions -28 and -21, respectively, from the 5' splice site of intron 9. The latter exonic mutation created a strong palindromic sequence (TGGGCTTGGAGAGCCCAA GAAAT/gt), which would result in an alteration of the pre-mRNA secondary structure in this region. Steingrimsdottir et al. (33) analyzed many mutants at the human hypoxanthine guanine phosphoribosyltransferase gene and detected 34 mutations that resulted in aberrant splicing. Among them, a mutation located 13 nucleotides from the 5' splice site of intron 8 caused exon 8 skipping in 90% of hypoxanthine guanine phosphoribosyltransferase transcripts. They attributed partial exon skipping to alteration of secondary structures by this substitution. These cases are similar to ours. Exonic mutations which affect 3' splice site selection were also noted in the human episialin gene and the human f3-hexosaminidase (3 subunit gene (34, 35) .
This study conclusively demonstrates the importance of exon sequences in splicing reactions; even a single nucleotide substitution can cause aberrant splicing.
